4Front Ventures Corp C.FFNT

Alternate Symbol(s): FFNTF

Healthcare

4Front Ventures Corp. is a multi-state cannabis operator and retailer. The Company owns or manages licensed cannabis facilities in state-licensed markets in the United States. It manufactures and distributes a portfolio of over 25 cannabis brands including Marmas, Crystal Clear, Island, Verdure, and the Pure Ratios wellness collection, which is distributed through retail outlets, as well as the Company’s chain of branded dispensaries. The Company's segments include THC Cannabis and CBD Wellness. The THC Cannabis segment is engaged in cultivation, production, manufacturing, and distribution of THC cannabis products to owned dispensaries and third-party retailers, ancillary services supporting wholesale operations, and retail sales direct to end consumers. It also leases real estate and sells equipment, supplies, and intellectual property to cannabis producers in the state of Washington. The Company’s CBD Wellness segment sells non-THC hemp derived products across the United States.

CSE:FFNT - Post by User

4Front Ventures Corp > Closes Accretive Acquisition of New England Cannabis Corp.

<< Previous

Bullboard Posts

Next >>

Post by Betteryear2on Jan 31, 2022 8:13am

202 Views

Post# 34377632

Closes Accretive Acquisition of New England Cannabis Corp.

Significantly expands strategic position and broadens market penetration in important limited-license state of Massachusetts

Acquisition expected to be immediately accretive to the Company's 2022 EBITDA

Fully operational, technologically advanced, 55,000 sq. ft. cultivation facility adds scale and depth in the State

PHOENIX, Jan. 31, 2022 /PRNewswire/ - 4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) ("4Front" or the "Company"), a vertically integrated, multi-state cannabis operator and retailer, today announced it has closed on the purchase of New England Cannabis Corporation ("NECC"), a best-in-class cannabis cultivator with state-of-the-art facilities based in Holliston, Massachusetts (the "Transaction"). The Massachusetts Cannabis Control Commission approved of the Transaction during its public meeting on January 20, 2022. The Transaction was first announced in the Company's press release dated October 7, 2021.